Pregnancy

Women and Asthma in the EU

European Institute of Women’s Health. October 2014.

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, asthma, policy, Pregnancy

Women and Diabetes in the EU

European Institute of Women’s Health. January 2013.

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, diabetes, cardivascular diseases, Pregnancy, policy

Women and Cardiovascular Disease in the EU

European Institute of Women’s Health. February 2013.

Traditionally regarded as a male disease, cardiovascular disease (CVD) is the number one killer of women worldwide. It also is a major cause of serious illness and disability, costly to healthcare systems and destroying women’s quality of life. In the EU, CVD remains the top cause of death for women in each of the twenty-seven EU countries. Only during the last decades has awareness been rising how CVD affects women differently from men, alerting women to their risk. 

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, cardivascular diseases, Pregnancy, policy

The winners for the ASSET best practice award

Thursday, February 23, 2017 - 16:30

The second edition of the ASSET best practice award for general practitioners has come to an end, with the assignment of the four grants to health professionals or groups of health professionals working in the primary health sector.

Target: 
Healthcare Professionals
Topic: 
Gender, Human Rights, Local Activities, Prevention, Stakeholders, Vaccination
Tags: 
gender issues, Vaccine, Vaccine hesitancy, Vaccine safety, Roma, Pregnancy

Vaccination in pregnancy: safe and effective

April 26, 2016

As it was proved during 2009 A(H1N1) pandemic, vaccinating pregnant women against flu is usually safe and can protect both mother and children. Vaccination against whooping cough is recommended as well, while vaccines with live virus, such as nasal spray flu vaccine, measles and rubella, should not be used in these cases. Thomas Breuer, GSK Senior Vice president, Chief Medical Officer, Vaccines, tells ASSET about a new approach to protect babies against a dangerous infection such as SRV (syncytial respiratory virus), by immunising mothers during pregnancy with a vaccine which is currently under study at GSK.

Target: 
Citizens, Healthcare Professionals
Topic: 
Gender, Prevention, Vaccination
Tags: 
Vaccine, Vaccine safety, Pregnancy, Video

Factors Associated with Intention to Receive Influenza and Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccines during Pregnancy

Chamberlain AT, Seib K, Ault KA, Orenstein WA, Frew PM, Malik F, et al. PLoS Curr. 2015 Feb 25;7.

Background: Improving influenza and tetanus, diphtheria and acellular pertussis (Tdap) vaccine coverage among pregnant women is needed.

Purpose: To assess factors associated with intention to receive influenza and/or Tdap vaccinations during pregnancy with a focus on perceptions of influenza and pertussis disease severity and influenza vaccine safety.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Vaccination
Tags: 
Vaccine, Vaccine hesitancy, Pregnancy, Tetanus, Diphteria, Acellular pertussis, Risk perception
Subscribe to Pregnancy

MMLAP and other EU Projects

AsiaFluCap
Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
BEWATER
Making society an active participant in water adaptation to global change
CASI
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
CIMULACT
Engaging all of Europe in shaping a desirable and sustainable future
DARWIN
Expect the unexpected and know how to respond
DRIVER
Driving innovation in crisis management for European resilience
ECOM
Effective communication in outbreak management: development of an evidence-based tool for Europe
EDEN
Solutions to improve CBRNe resilience
EPISOUTH
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
EPIWORK
Developing the framework for an epidemic forecast infrastructure
EUPHARE
Strengthening of the national surveillance system for communicable diseases
EUROHEP
Surveillance of vaccine preventable hepatitis
EuroMOMO
European monitoring of excess mortality for public health action
EURONHID
European network for highly infectious disease
EUVAC.NET
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
FLUMODCONT
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
FLURESP
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
GAP2
Bridging the gap between science, stakeholders and policy makers
HProImmune
Promotion of immunization for health professionals in Europe
INPROFOOD
Towards inclusive research programming for sustainable food innovations
JA-CHRODIS
Addressing chronic diseases and healthy ageing across the life cycle
M-Eco
Medical ecosystem – personalized event-based surveillance
MAPPING
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
MARINA
Get involved in the responsible marine research and innovation
PACITA
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
PANDEM
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
PE2020
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
PERARES
Public Engagement with Research And Research Engagement with Society
PHEME
Computing Veracity – the Fourth Challenge of Big Data
PREPARE
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
PROMOVAX
Promote vaccinations among migrant population in Europe
R&DIALOGUE
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
RESPIRE
Improve the quality of indoor air, keeping it free from radon
SATORI
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
SECURING CITIES AGAINST GLOBAL PANDEMICS
Investigating how cities in the West securitise against global pandemics
SEiSMiC
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
SIS CATALYST
Identifying how children can be change agents in the Science and Society relationship
SYN-ENERGENE
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
TELLME
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence